Canadian Prime Minister Justin Trudeau declared the 5th Replenishment Conference a success, with pledges from governments, private sector, and individual donors reaching US$ 12.9 billion. This will finance the implementation of the new Global Fund strategy, which puts greater emphasis on key population-focussed interventions and human rights-informed and gender transformative programming.
Since its establishment, the Global Fund has invested US$ 6.6 billion in the Asia-Pacific region, saving 9.4 million lives in the region. It has provided anti-retroviral treatment access to 1.2 million people, has supported 9.6 million TB treatments, and distributed 80 million mosquito nets.
The end of the Replenishment Conference signals the beginning of the next cycle of funding applications from Global Fund-eligible countries. Asia-Pacific countries are known as early applicants, and here are some key points that civil society, communities and key populations need to know.
Did you miss the 5th Replenishment Conference? Watch this video from Global Affairs Canada.
Co-financing, transitioning and eligibility
With the changing financing landscape, it is important for countries to seriously consider how to sustain and scale up their HIV, TB, and malaria programs. Take note that under the new Global Fund strategy and the recently approved co-financing, sustainability and transition policy, countries will be supported to develop plans to transition out of donor support and will be required and incentivized to increase further their domestic investments in the three diseases.
Except for Fiji, which was already transitioning out of the Global Fund in the beginning of the current funding model, the eligibility status of Asia-Pacific countries is unlikely to change for the next cycle. Furthermore, under the transition policy, transitioning out of the Global Fund will be a slow, measured process, hence the support for the development of transition plans.
Fiji remains eligible to join in multi-country grants. Thailand, which announced in 2014 its intent to transition out of the Global Fund, remains eligible to apply for funding. (See below the eligibility status of Asia-Pacific countries based on the 2014-2016 allocation period).
Country allocations and disease split for 2014-2016 Allocation Period, in US millions, for Asia-Pacific region
Allocation per country
With the Replenishment Conference over, the Global Fund secretariat will run the eligible countries through the allocation methodology. The country’s income classification or ability to pay and disease burden will affect the amount of total funding that the country will get. Countries will also have maximum and minimum allocations, and other qualitative factors (such as previous grant performance, impact, incidence rate, risks and challenging environments, etc.) will also be considered in adjusting a country’s share.
GF-eligible countries will be notified before the end of 2017 of the total funding that each country will receive for this allocation cycle.
Determining disease split
The Global Fund will also inform the countries of how the country allocation is split between the three diseases. However, Country Coordinating Mechanisms (CCMs) can decide on how to adjust this split after receiving the notification from the Global Fund secretariat, with approval from the Global Fund. They can shift a portion of the allocation for a disease to another disease, or reallocate some portions to support a grant for health systems strengthening.
Note that under the eligibility requirement for the CCM, decisions like this require the participation of civil society, communities, and key populations. Ask your CCM secretariat and your CCM representatives when this decision will take place, and how you can engage in the process. CSOs, community groups, and key population networks from the three diseases should collaborate and coordinate to ensure that the allocation split is based on evidence and the country’s strategic plans and financing priorities.
Funding model timelines
The replenishment conference kickstarts the next cycle of funding applications. Please consider the following to ensure the participation of civil society, communities, and key populations and to strengthen the inclusion of human rights and gender equality in country disease programmes:
- Concept Notes need to be based in up-to-date country priorities. Take part in the development of National Strategic Plans (NSPs) or their periodic review or in disease Investment Cases (ICs) to ensure that key populations, human rights, and gender equality are integrated in country priorities. The NSPs or ICs become the basis for the strategies and interventions included in the Concept Note.
- CCMs are required to organise regular Country Dialogues all throughout the the funding application process. Ask your CCM secretariat for the schedule of the Country Dialogues, and how you can participate or be represented in this process.
- Prepare for the funding application process. Gather evidence for the inclusion of key population programs, or for interventions on human rights or gender equality. Here’s a tool you can use to understand your CRG needs.
- Check with development partners in your country how they can support the involvement of civil society, communities, and key populations in the funding application process. In case support is not available, check out the CRG Technical Assistance Programme and see if this facility can help you.
Read about the key stages of the Funding Model to understand about the stages of the funding application process and where and how you can get involved.
The APCRG is the Asia-Pacific Platform on Communities, Rights, and Gender. We can help you engage in Global Fund processes to guarantee that country programs are inclusive of key populations, human rights, and gender equality. Sign up below to get more useful information, tools, and resources about the Global Fund and the funding application process.